Ask Warren

Bio-Fd&C

251120 · KOSDAQ · ₩251120 · 바이오에프디엔씨

₩9,140▼ ₩60 (0.65%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩5.4B₩4B₩5.1B₩5.1B₩4.7B₩4.3B₩4.7B₩3.6B
Cost of sales₩1.5B₩1.3B₩2.1B₩1.7B₩1.3B₩1.2B₩1.6B₩931M
Gross profit₩3.8B₩2.7B₩3B₩3.4B₩3.4B₩3.1B₩3.2B₩2.7B
Operating income₩2.1B₩1B₩1.3B₩1.7B₩1.8B₩1.4B₩1.6B₩1.1B
Net income₩2B₩1.2B₩1.3B₩1.9B₩1.8B₩1.6B₩1.8B₩1.1B
Net income to shareholders₩2B₩1.2B₩1.3B₩1.9B₩1.8B₩1.6B₩1.8B₩1.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩76B₩75B₩73B₩72B₩70B₩69B₩67B₩66B
Current assets₩61B₩60B₩58B₩57B₩53B₩53B₩51B₩49B
Cash and equivalents₩12B₩12B₩11B₩11B₩8.6B₩8.7B₩7.7B₩8.5B
Total liabilities₩3.4B₩3.5B₩3.7B₩3.8B₩3B₩4.2B₩4.2B₩4.2B
Current liabilities₩3.2B₩3.3B₩3.4B₩3.5B₩2.7B₩4B₩4B₩4B
Borrowings₩1.1B₩100M₩100M₩100M₩100M₩1.2B₩1.2B₩1.2B
Total equity₩73B₩71B₩70B₩68B₩67B₩65B₩63B₩61B
Shareholders' equity₩73B₩71B₩70B₩68B₩67B₩65B₩63B₩61B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩2B₩993M₩1.5B₩1.9B₩2.5B₩1.4B₩1.9B₩1.7B
Capital spending₩195M₩88M₩231M₩185M₩510M₩48M₩197M₩142M
Free cash flow₩1.8B₩906M₩1.3B₩1.7B₩1.9B₩1.3B₩1.7B₩1.5B

Consolidated where available. Amounts in won.

Also known as: Bio-Fd&C / 바이오에프디엔씨 / 251120 / KRX:251120

Source: KRX statistical information